These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 2756732

  • 21. [Mitochondria number as a prognostic parameter in dilated cardiomyopathy. A long-term follow-up study].
    Kahler M, Schwaiger A, Mühlberger V, Moes N, Ludescher C, Dietze O, Knapp E.
    Z Kardiol; 1990 Nov; 79(11):748-52. PubMed ID: 2278167
    [Abstract] [Full Text] [Related]

  • 22. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D, Napoli V, Passantino A, Ricci A, Lagioia R, Rizzon P.
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [Abstract] [Full Text] [Related]

  • 23. Myocyte diameter and fractional area of collagen are not associated with survival time of outpatients with idiopathic dilated cardiomyopathy: a study based on right ventricular endomyocardial biopsies.
    Benvenuti LA, Freitas HF, Mansur AJ, Higuchi ML.
    Int J Cardiol; 2007 Mar 20; 116(2):279-80. PubMed ID: 16839625
    [Abstract] [Full Text] [Related]

  • 24. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
    Becker R, Haass M, Ick D, Krueger C, Bauer A, Senges-Becker JC, Voss F, Hilbel T, Niroomand F, Katus HA, Schoels W.
    Basic Res Cardiol; 2003 Jul 20; 98(4):259-66. PubMed ID: 12835955
    [Abstract] [Full Text] [Related]

  • 25. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.
    Miettinen KH, Eriksson S, Magga J, Tuomainen P, Kuusisto J, Vanninen EJ, Turpeinen A, Punnonen KR, Pettersson K, Peuhkurinen KJ.
    J Card Fail; 2008 Aug 20; 14(6):481-8. PubMed ID: 18672196
    [Abstract] [Full Text] [Related]

  • 26. [Predictive value of myocellular hypertrophy in idiopathic dilated cardiomyopathy].
    Gallo P, Cianfrocca C, Pelliccia F, Bernucci P, d'Amati G, Scibilia G, Nigri A, Romeo F, Reale A.
    Cardiologia; 1989 Jan 20; 34(1):53-60. PubMed ID: 2720714
    [Abstract] [Full Text] [Related]

  • 27. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
    Matsumiya G, Monta O, Fukushima N, Sawa Y, Funatsu T, Toda K, Matsuda H.
    J Thorac Cardiovasc Surg; 2005 Sep 20; 130(3):699-704. PubMed ID: 16153916
    [Abstract] [Full Text] [Related]

  • 28. Sympathetic activity in idiopathic dilated cardiomyopathy. Influence of captopril and hydralazine.
    Schofer J, Bleifeld W.
    Cardiovasc Drugs Ther; 1987 Aug 20; 1(2):177-81. PubMed ID: 3154321
    [Abstract] [Full Text] [Related]

  • 29. [Is there a clinical value of endomyocardial biopsy and immunosuppressive treatment in idiopathic dilated cardiomyopathy? Study by meta analysis].
    Berensztein CS, Lerman J, Suárez LD.
    Medicina (B Aires); 1991 Aug 20; 51(4):315-21. PubMed ID: 1840400
    [Abstract] [Full Text] [Related]

  • 30. Prognostic role of myocardial tumor necrosis factor-alpha and terminal complement complex expression in patients with dilated cardiomyopathy.
    Zimmermann O, Kochs M, Zwaka TP, Bienek-Ziolkowski M, Höher M, Hombach V, Torzewski J.
    Eur J Heart Fail; 2007 Jan 20; 9(1):51-4. PubMed ID: 16730227
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
    Regitz V, Fleck E.
    Am J Cardiol; 1992 Jun 15; 69(19):1574-80. PubMed ID: 1598872
    [Abstract] [Full Text] [Related]

  • 33. Myocardial catecholamine concentrations in dilated cardiomyopathy and heart failure of different origins.
    Regitz V, Leuchs B, Bossaller C, Sehested J, Rappolder M, Fleck E.
    Eur Heart J; 1991 Aug 15; 12 Suppl D():171-4. PubMed ID: 1915450
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Myocardial catecholamines in primary heart muscle disease: fact or fancy?
    Seferović PM, Maksimović R, Ostojić M, Stepanović S, Nikolić J, Vasiljević JD, Kanjuh V, Seferović D, Simeunović S, Ristić A.
    Eur Heart J; 1995 Dec 15; 16 Suppl O():124-7. PubMed ID: 8682078
    [Abstract] [Full Text] [Related]

  • 37. Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics.
    Schwarz F, Mall G, Zebe H, Schmitzer E, Manthey J, Scheurlen H, Kübler W.
    Circulation; 1984 Dec 15; 70(6):923-8. PubMed ID: 6499148
    [Abstract] [Full Text] [Related]

  • 38. Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction.
    Frustaci A, Magnavita N, Chimenti C, Caldarulo M, Sabbioni E, Pietra R, Cellini C, Possati GF, Maseri A.
    J Am Coll Cardiol; 1999 May 15; 33(6):1578-83. PubMed ID: 10334427
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.